DTRT Health Acquisition Corp. (NASDAQ:DTRT) announced this afternoon that it convened and then adjourned today’s special meeting, without conducting any other business.
The SPAC disclosed that it has adjourned the meeting in order to provide additional time to effectuate the extension timeline for its proposed merger with Consumer Direct. As of now, DTRT Health has a deadline of December 6, but is hoping to add three months on its clock to obtain a new deadline of March 7, 2023.
The meeting will reconvene on December 6, at 3:00 p.m. Central Time.
DTRT recently inked its $681 million deal with healthcare company Consumer Direct on September 29. Missoula, Montana-based Consumer Direct offers self-directed home care to disabled and elderly clients in 14 states through Medicaid, private insurance and managed healthcare plans.
Terms Tracker for the Week Ending January 27, 2022 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. We’re coming up on the end of January, the first month of the year, and to-date no new S-1s have been filed. Additionally, the number...
Below is a daily summary of links to the latest SPAC news and rumors gathered across the web. Latest SPAC News: Circle spokesperson denies blaming SEC for failed deal, BuzzFeed CEO says AI-powered content will be part of core business, and FaZe Clan faces possible delisting Circle Spokesperson Denies Blaming SEC for Failed $9 Billion Deal...
Health Sciences 2 (NASDAQ:HSAQ) announced that it closed its combination with Orchestra BioMed on January 26. HSAQ ahead of its vote pre-announced redemption figures of 1,597,888 shares equating to 67.7% redemptions, however, that’s still subject to change. However, today it was noted that Orchestra BioMed is to receive $70 million in gross proceeds including $20...
Carbon capture technology has long been talked about, and it is finally in operation with LanzaTech among the pioneers. Its plants are turning potential emissions into clothing, household goods and sustainable fuels. SPAC cash is now also an accelerant in this new process as the company announced a $1.7 billion combination with AMCI II last March. This week, we caught up with...
In this series we’ll be examining successful SPAC deals from the past both in the terms and circumstances of their de-SPAC processes and how they have weathered the storms that have followed after their public listings with research from SPACInsider contributor Anthony Sozzi. Thirty months does not sound like that long, but it’s been a...